100 Clinical Results associated with Ocean Ophthalmology Group LLC
0 Patents (Medical) associated with Ocean Ophthalmology Group LLC
01 Jan 2020·Therapeutic advances in ophthalmology
Reducing transmission of SARS-CoV-2 in ophthalmology with nasal and oral decontamination
Article
Author: Stewart, Kevin ; Pelletier, Jesse S. ; Tessema, Belachew
01 Dec 2017·Ophthalmology and therapyQ3 · MEDICINE
Demodex Blepharitis Treated with a Novel Dilute Povidone-Iodine and DMSO System: A Case Report
Q3 · MEDICINE
ArticleOA
Author: Capriotti, Joseph A ; Stewart, Kevin S ; Capriotti, Kara ; Pelletier, Jesse S
INTRODUCTION:Povidone-iodine aqueous solution is an antiseptic commonly used in ophthalmology for treatment of the ocular surface. Dimethylsulfoxide (DMSO) is a well-known skin penetration enhancer that is scarcely utilized in ophthalmic drug formulations. We describe here a low-dose formulation of 0.25% PVP-I in a gel containing DMSO for the treatment of Demodex blepharitis.
CASE REPORT:A 95-year-old female presented with chronic blepharitis involving both the anterior and posterior eyelid margins. The anterior eyelid margins demonstrated pathognomonic features consistent with Demodex infection, and this diagnosis was confirmed with microscopy. Previous traditional therapies had been ineffective at controlling her signs and symptoms.
CONCLUSION:The topical PVP-I/DMSO system was effective at treating the signs and symptoms of Demodex blepharitis. Further investigation of the novel agent is warranted.
01 Dec 2015·Ophthalmology and therapyQ3 · MEDICINE
Rosacea Blepharoconjunctivitis Treated with a Novel Preparation of Dilute Povidone Iodine and Dimethylsulfoxide: a Case Report and Review of the Literature
Q3 · MEDICINE
ArticleOA
Author: Capriotti, Joseph A ; Stewart, Kevin P ; Pelletier, Jesse S ; Capriotti, Kara
INTRODUCTION:Povidone iodine (PVP-I) 10% aqueous solution is a commonly utilized anti-septic employed for sterilization of the ocular surface prior to interventional procedures. Dimethylsulfoxide (DMSO) is a well-known skin penetration agent scarcely utilized in ophthalmic drug formulations. We describe here a low-dose formulation of 1% PVP-I (w/w) in a gel containing DMSO for use in the setting of recalcitrant rosacea blepharoconjunctivitis. A review of the ocular uses of dimethylsulfoxide is also presented.
CASE REPORT:A 78-year-old male presented with chronic, long-standing blepharitis involving both the anterior and posterior lid margins. Posterior lid and skin inflammatory changes were consistent with ocular rosacea. Previous oral and topical therapies had been largely ineffective at controlling his condition.
CONCLUSION:The topical PVP-I/DMSO system was effective in abating the signs and symptoms of rosacea blepharoconjunctivitis. Further investigation of this novel agent is warranted.
100 Deals associated with Ocean Ophthalmology Group LLC
100 Translational Medicine associated with Ocean Ophthalmology Group LLC